Catalent
CTLT
#1856
Rank
โ‚น1.089 T
Marketcap
โ‚น6,000
Share price
0.00%
Change (1 day)
24.52%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น598.28. In 2023 the company made an earnings per share (EPS) of -โ‚น642.70 a decrease over its 2022 EPS that were of โ‚น214.55.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-17.98%
2023-โ‚น642.70-399.56%
2022โ‚น214.55-30.58%
2021โ‚น309.0679.67%
2020โ‚น172.02114.12%
2019โ‚น80.34-15%
2018โ‚น94.5175.44%
2017โ‚น53.87-22.97%
2016โ‚น69.94-59.56%
2015โ‚น172.96282.05%
2014โ‚น45.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น64.27-89.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น43.48-107.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น70.89-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น139.88-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA